Astrocyte Delivery of Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease

By Cunningham L.A.   Su C.  

Experimental Neurology, Vol. 174, Iss. 2, 2002-04 ,pp. : 230-242

Elsevier

Access to resources Recommend Favorite

Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

By Lapchak P.A.   Gash D.M.   Collins F.   Hilt D.   Miller P.J.   Araujo D.M.  

Experimental Neurology, Vol. 145, Iss. 2, 1997-06 ,pp. : 309-321

Elsevier

Access to resources Recommend Favorite

Mutation Analysis of the Glial Cell Line-Derived Neurotrophic Factor Gene in Parkinson's Disease

By Wartiovaara K.   Hytonen M.   Vuori M.   Paulin L.   Rinne J.   Sariola H.  

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 307-309

Elsevier

Access to resources Recommend Favorite

Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease

By Mandel R.J.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 205-214

Elsevier

Access to resources Recommend Favorite

Intracerebroventricular Glial Cell Line-Derived Neurotrophic Factor Improves Motor Function and Supports Nigrostriatal Dopamine Neurons in Bilaterally 6-Hydroxydopamine Lesioned Rats

By Bowenkamp K.E.   Lapchak P.A.   Hoffer B.J.   Miller P.J.   Bickford P.C.  

Experimental Neurology, Vol. 145, Iss. 1, 1997-05 ,pp. : 104-117

Elsevier

Access to resources Recommend Favorite